Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

138610.KQ

STRONG SELL

NIBEC Co., Ltd. · Healthcare · South Korea · $141M · Avg Vol: $743K/d

14
StockRank
Q
65
V
24
M
11
P/E (TTM)
45.1x
ROE
18.8%
D/E
0.2x
Dividend %
—
Director Trades · 180d
None in 180d →
Buybacks · 180d
None in 180d →

COMPANY DESCRIPTION

NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGR
Revenue14M10M16M22M14.7%
EPS-0.25-0.42-0.590.27—
Shares10M10M11M11M+13.6%
Debt14M15M11M7M-23.1%
Equity22M19M21M30M11.5%
Op CF4M-1M191,7214M2.3%
Inv CF-4M-322,906901,737-3M—
Fin CF8M-3M-475,567-2M—
Loading...
PRICE (1M)-25.0%
11.4712.6213.7714.9116.06May 6May 28Jun 18
SMA 50SMA 200
Close
$12.04
RSI (14)
31.6
52W High
$35.74
From 52W High
0.3%

SCORE BREAKDOWN

Quality
65
ROIC
10.0%73.5
ROE
18.8%87.4
GP/Assets
32.7%69.4
Op. Margin
2.6%50.0
FCF/Assets
-5.1%35.7
Piotroski
—83.4
Int. Cover
10.1x64.5
D/E Ratio
0.21x51.5
Current Ratio
3.35x57.7
Value
24
P/E (TTM)
45.1x22.8
EV/EBITDA
20.9x17.5
P/FCF
—N/A
P/B
4.6x26.2
P/S
6.5x33.6
Div Yield
—N/A
Momentum
11
52W High %
34%7.9
RS 6M
-177%0.5
SMA 50/200
0.74x7.2
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$141M
P/E (Forward)
—
Gross Margin
63.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 138610.KQ are excluded.

TickerCompanyMkt CapStockRankSignal
138610.KQNIBEC Co., Ltd.(you)$141M14STRONG SELL
308080.KQViGenCell Inc.$135M12STRONG SELL
115450.KQHLB Therapeutics Co.,Ltd.$147M15STRONG SELL
314130.KQGenome & Company$146M16STRONG SELL
308430.KQCellbion$150M8STRONG SELL
321550.KQTiumBio Co., Ltd.$127M7STRONG SELL
086820.KQBiosolution Co.,Ltd.$127M21SELL
394800.KQ3billion$154M6STRONG SELL
217730.KQKangstem Biotech Co., Ltd.$189M18STRONG SELL
389650.KQNEXTBIOMEDICAL$217M12STRONG SELL

Peer medians: ROE -1.3% · P/E 17.6x · Gross margin 43.4%

NIBEC Co., Ltd. (138610.KQ) — Stock Score Summary

NIBEC Co., Ltd. (138610.KQ) has a MoatMap StockRank of 14/100 based on Quality (65/100), Value (24/100), and Momentum (11/100) factor scores. The current signal is STRONG SELL.

NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally.

Key Financial Metrics

Price$12.04
Market Cap$141M
P/E (TTM)45.07
Price/Book4.63
Return on Equity18.8%
Return on Invested Capital10.0%
Debt/Equity20.65
Gross Margin63.7%
Operating Margin2.6%
Revenue Growth-6.7%
Free Cash Flow$-1K

NIBEC Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is NIBEC Co., Ltd.’s (138610.KQ) StockRank?
MoatMap’s StockRank for NIBEC Co., Ltd. (138610.KQ) is 14/100, with a Strong Sell signal. It is a composite of Quality (65), Value (24), and Momentum (11) factor ranks across MoatMap’s 20,000+ stock universe.
Does NIBEC Co., Ltd. have an economic moat?
NIBEC Co., Ltd. (138610.KQ) has a Quality factor score of 65/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is NIBEC Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for NIBEC Co., Ltd. (138610.KQ) is Strong Sell, based on a StockRank of 14/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is NIBEC Co., Ltd. in?
NIBEC Co., Ltd. (138610.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).
Browse all ranked stocks138610.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock